Sponsors / LKFT
LKFT

Lakefront Biotherapeutics NV

Company identity checked against sources

Browse linked trials and recorded changes, or follow this company for updates.

Follow company
11Trials in this database
6Recorded changes · last 12 months
Partial coverageOnly the trials and history collected so far

Research sample: selected versions from May 2023 onward plus a preceding baseline where available. Only selected fields were retained; endpoint measures were truncated to 300 characters. This is not complete trial or sponsor history. Daily snapshots begin when collection starts.

Completion dates · Pro

Which trial dates moved later?

Pro summarizes how far estimated completion dates moved later and counts trials with edits to their main study measures, using the history available here. View Pro features

Included trials

Check company identity source
TrialSponsorPhaseStatusPrimary completion
Long-term Follow-up Study of GLPG0634 in Active Rheumatoid Arthritis ParticipantsNCT02065700LKFTPhase 2Completed2023-01-19Actual
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's DiseaseNCT02914561LKFTPhase 3Completed2022-11-11Actual
Filgotinib in Long-Term Extension Study of Adults With Crohn's DiseaseNCT02914600LKFTPhase 3Terminated2023-08-01Actual
Study to Evaluate the Testicular Safety of Filgotinib in Adult Males With Moderately to Severely Active Inflammatory Bowel DiseaseNCT03201445LKFTPhase 2Terminated2020-11-20Actual
Study to Evaluate the Effect of Filgotinib on Semen Parameters in Adult Males With Active Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, or Non-radiographic Axial SpondyloarthritisNCT03926195LKFTPhase 2Completed2020-08-14Actual
A Study to Evaluate the Effects of GLPG2737 in Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)NCT04578548LKFTPhase 2Terminated2022-12-14Actual
A Study Evaluating the Effects of GLPG3970 Given as an Oral Treatment for 12 Weeks in Adults With Active Primary Sjögren's Syndrome (pSS)NCT04700280LKFTPhase 2Terminated2021-10-28Actual
A Study Evaluating the Effect of Filgotinib Dose De-escalation in Participants With Ulcerative Colitis (UC) in RemissionNCT05479058LKFTPhase 3Terminated2023-10-09Actual
A Study Evaluating the Effects of GLPG3667 Given as Oral Treatment for up to 24 Weeks in Adults With DermatomyositisNCT05695950LKFTPhase 2Completed2025-10-13Actual
A Study Evaluating the Effects of GLPG3667 Administered as Oral Treatment in Adult Participants With Active Systemic Lupus ErythematosusNCT05856448LKFTPhase 2Completed2025-10-08Actual
Long-term Follow-up of Participants Treated With Galapagos Chimeric Antigen Receptor (CAR) T-cell TherapiesNCT06652633LKFTPhase 3Recruiting2039-07Estimated

Latest recorded trial changes